BioMed Realty Trust Says Underwriters' Exercised Overallotment Option

BioMed Realty Trust, Inc.

today announced the full exercise of the underwriters' option to purchase additional shares of common stock in connection with BioMed Realty's previously announced follow-on offering that priced on March 27, 2013. In total, the company sold 17,250,000 shares of common stock in the offering, raising gross offering proceeds of approximately $369.2 million. Morgan Stanley & Co. LLC, Raymond James & Associates, Inc., UBS Securities LLC, Wells Fargo Securities, LLC and KeyBanc Capital Markets Inc. are the joint book-running managers for the offering.